Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers.
暂无分享,去创建一个
Smita Y. Patel | A. Fischer | J. Hugot | H. Kanegane | C. Picard | N. Brousse | H. Uhlig | L. Siproudhis | L. Galicier | C. Lenoir | S. Latour | B. Neven | S. Koletzko | H. Chapel | T. Schwerd | F. Ruemmele | M. Schäppi | M. Mori | M. Roy | D. Berrebi | D. Canioni | A. Yamaide | J. Routes | N. Lambert | B. Bègue | Stéphane Gérart | C. Aguilar | A. Al-Ahmari | N. C. Bensussan
[1] K. Schwarz,et al. A new functional assay for the diagnosis of X‐linked inhibitor of apoptosis (XIAP) deficiency , 2014, Clinical and experimental immunology.
[2] P. Rosenstiel,et al. XIAP variants in male Crohn's disease , 2014, Gut.
[3] S. Ehl,et al. XIAP deficiency is a mendelian cause of late-onset IBD , 2013, Gut.
[4] K. Schwarz,et al. X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis. , 2013, Clinical immunology.
[5] Xing Huang,et al. XIAP inhibits autophagy via XIAP‐Mdm2‐p53 signalling , 2013, The EMBO journal.
[6] N. Mailand,et al. Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling , 2013, EMBO molecular medicine.
[7] A. Fischer,et al. Human iNKT and MAIT cells exhibit a PLZF-dependent proapoptotic propensity that is counterbalanced by XIAP. , 2013, Blood.
[8] D. Lewinsohn,et al. Co-dependents: MR1-restricted MAIT cells and their antimicrobial function , 2012, Nature Reviews Microbiology.
[9] A. Strasser,et al. The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity. , 2012, Molecular cell.
[10] A. Groth,et al. H3K56me1 marks a spot for PCNA. , 2012, Molecular cell.
[11] H. Kanegane,et al. Clinical and Genetic Characteristics of XIAP Deficiency in Japan , 2012, Journal of Clinical Immunology.
[12] C. Klein,et al. IL‐10 and IL‐10 receptor defects in humans , 2011, Annals of the New York Academy of Sciences.
[13] Joshua M. Korn,et al. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease , 2011, Nature Genetics.
[14] Judy H. Cho,et al. NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2 , 2011, Gut.
[15] A. Fischer,et al. Human X-linked variable immunodeficiency caused by a hypomorphic mutation in XIAP in association with a rare polymorphism in CD40LG. , 2011, Blood.
[16] Tomohiro Watanabe,et al. NOD2, an Intracellular Innate Immune Sensor Involved in Host Defense and Crohn's Disease , 2011, Mucosal Immunology.
[17] R. Xavier,et al. Genetics and pathogenesis of inflammatory bowel disease , 2011, Nature.
[18] David P Bick,et al. Making a definitive diagnosis: Successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease , 2011, Genetics in Medicine.
[19] A. Fischer,et al. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). , 2011, Blood.
[20] A. Filipovich,et al. Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency. , 2010, Journal of immunological methods.
[21] A. Schäffer,et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. , 2009, The New England journal of medicine.
[22] T. Sweeting,et al. Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease , 2009, The Journal of experimental medicine.
[23] Laurent Abel,et al. Revisiting Crohn's disease as a primary immunodeficiency of macrophages , 2009, The Journal of experimental medicine.
[24] J. B. Garrison,et al. XIAP mediates NOD signaling via interaction with RIP2 , 2009, Proceedings of the National Academy of Sciences.
[25] M. Netea,et al. A Crohn's disease–associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1 , 2009, Nature Immunology.
[26] M. Novelli,et al. Inflammatory Bowel Disease in CGD Reproduces the Clinicopathological Features of Crohn's Disease , 2009, The American Journal of Gastroenterology.
[27] S. Shirasawa,et al. Detachment-induced upregulation of XIAP and cIAP2 delays anoikis of intestinal epithelial cells , 2006, Oncogene.
[28] F. Rieux-Laucat,et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome , 2006, Nature.
[29] G. Salvesen,et al. Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family , 2006, EMBO reports.
[30] Clive M. Onnie,et al. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease , 2005, The Lancet.
[31] L. Jacobs,et al. Nucleotide-Binding Oligomerization Domain-2 Modulates Specific TLR Pathways for the Induction of Cytokine Release 1 , 2005, Journal of Immunology.
[32] Judy H. Cho,et al. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations. , 2004, Human molecular genetics.
[33] Mourad Sahbatou,et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.
[34] Judy H. Cho,et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease , 2001, Nature.
[35] L. del Peso,et al. Nod1, an Apaf-1-like Activator of Caspase-9 and Nuclear Factor-κB* , 1999, The Journal of Biological Chemistry.
[36] David C. Wilson,et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.
[37] D. Jewell,et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation , 2010, Nature Medicine.
[38] D. Philpott,et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry , 2010, Nature Immunology.
[39] C. Duckett,et al. XIAP as a ubiquitin ligase in cellular signaling , 2010, Cell Death and Differentiation.
[40] Tomohiro Watanabe,et al. Signalling pathways and molecular interactions of NOD1 and NOD2 , 2006, Nature Reviews Immunology.